Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Haemonetics Corporation Common Stock (NY: HAE )

60.34 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EDT, Apr 23, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 633
Open 60.34
Bid (Size) 24.14 (2)
Ask (Size) 69.96 (1)
Prev. Close 60.34
Today's Range 60.34 - 60.34
52wk Range 55.30 - 97.97
Shares Outstanding 51,029,618
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
How Do Investors Really Feel About Haemonetics?
Via Benzinga
HAEMONETICS CORP/MASS (NYSE:HAE) is an undervalued gem with solid fundamentals.
HAEMONETICS CORP/MASS has caught the attention as a great value stock. NYSE:HAE excels in profitability, solvency, and liquidity, all while being very reasonably priced. 
Via Chartmill

Performance

YTD
-23.04%
-23.04%
1 Month
-6.38%
-6.38%
3 Month
-17.74%
-17.74%
6 Month
-17.67%
-17.67%
1 Year
-29.07%
-29.07%

More News

Read More
Spotting Winners: STAAR Surgical (NASDAQ:STAA) And Medical Devices & Supplies - Specialty Stocks In Q4
Via StockStory
BD, Teleflex, Insulet, UFP Technologies, and Haemonetics Shares Are Falling, What You Need To Know
Via StockStory
Topics Economy Government World Trade
Exposures Economy Political Tariff
How Do Investors Really Feel About Haemonetics?
Via Benzinga
(HAE) - Analyzing Haemonetics's Short Interest
Via Benzinga
Haemonetics Stock: A Deep Dive Into Analyst Perspectives (5 Ratings)
Via Benzinga
Medical Devices & Supplies - Specialty Stocks Q4 Teardown: Integer Holdings (NYSE:ITGR) Vs The Rest
Via StockStory
Medical Devices & Supplies - Specialty Stocks Q3 Recap: Benchmarking STAAR Surgical (NASDAQ:STAA)
Via StockStory
Q4 Earnings Roundup: Bausch + Lomb (NYSE:BLCO) And The Rest Of The Medical Devices & Supplies - Specialty Segment
Via StockStory
Earnings Scheduled For February 6, 2025
Via Benzinga
How Is The Market Feeling About Haemonetics?
Via Benzinga
Q4 Earnings Highs And Lows: Haemonetics (NYSE:HAE) Vs The Rest Of The Medical Devices & Supplies - Specialty Stocks
Via StockStory
3 Reasons to Avoid HAE and 1 Stock to Buy Instead
Via StockStory
Topics Supply Chain
Exposures Supply Chain
3 Healthcare Stocks Walking a Fine Line
Via StockStory
Topics Stocks
Exposures COVID-19 US Equities
Demystifying Haemonetics: Insights From 5 Analyst Reviews
Via Benzinga
HAEMONETICS CORP/MASS (NYSE:HAE) is probably undervalued for the fundamentals it is displaying.
Via Chartmill
Medical Devices & Supplies - Specialty Stocks Q4 In Review: Globus Medical (NYSE:GMED) Vs Peers
Via StockStory
A Look Back at Medical Devices & Supplies - Specialty Stocks’ Q3 Earnings: STAAR Surgical (NASDAQ:STAA) Vs The Rest Of The Pack
Via StockStory
Bausch + Lomb (BLCO) Reports Earnings Tomorrow: What To Expect
Via StockStory
Inspire Medical Systems (INSP) To Report Earnings Tomorrow: Here Is What To Expect
Via StockStory
For those who appreciate value investing, NYSE:HAE is a compelling option with its solid fundamentals.
Via Chartmill
Haemonetics (NYSE:HAE) Misses Q4 Revenue Estimates
Via StockStory
Earnings To Watch: Haemonetics (HAE) Reports Q4 Results Tomorrow
Via StockStory
While growth is established for NYSE:HAE, the stock's valuation remains reasonable.
Via Chartmill
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.